• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Exclusives
    • Nutraceuticals
    • Markets
    • Health
    • Jobs
    • Events
    • Buyers' Guide
    • Showcases
    • More
  • Magazine
  • News
  • Exclusives
  • Nutraceuticals
  • Markets
  • Health
  • Jobs
  • Events
  • Buyers' Guide
  • Showcases
  • Current & Past Issues
    Features
    Columns
    Editorials
    Digital Edition
    Subscribe Now
    Advertise Now
    eNewsletter
    Editorial Guidelines
    Top Features
    Fueling Cognitive Health through Nutrition & Supplementation

    2020 State of the Industry: High Expectations

    2020 International Buyers' Guide

    Clean Label Questions: Anything But ‘Short and Sweet’

    Key Trends in Functional Foods & Beverages for 2020
    Breaking News
    Certifications, Approvals and Patents
    Exclusives
    Industry & Market News
    People
    Products
    Regulatory
    Research
    Supplier News
    Live From Shows
    Top News
    Deerland Obtains Certification from Australia’s Therapeutic Goods Administration

    OptiMSM Shown to Improve Hair & Nail Appearance and Condition

    DCC Acquires Contract Manufacturer Ion Laboratories

    AquaCelle Delivery Technology Shown to Improve Omega-3 Absorption

    Mintel Identifies Global Food and Drink Trends Over Next 10 Years
    Exclusives
    Blogs & Guest Articles
    Health E-Insights
    Area Code 420
    eBook
    Antioxidants
    Dairy-Based Ingredients
    Enzymes
    Fatty Acids
    Fiber & Carbohydrates
    Green Foods
    Herbs & Botanicals
    Marine Nutraceuticals
    Minerals
    Omega 3s
    Probiotics & Prebiotics
    Proteins, Peptides, Amino Acids
    Sweeteners
    Vitamins

    OptiMSM Shown to Improve Hair & Nail Appearance and Condition

    AquaCelle Delivery Technology Shown to Improve Omega-3 Absorption

    Cannabinoid Testing & Quality: Michael Poleselli on the VivAssure Standard

    Mood33 to Introduce Hemp-Infused Herbal Teas Featuring Evo Hemp

    Elixinol Gains USDA Organic Certification for CBD Tincture
    Consumer Trends
    Contract Manufacturing
    Cosmeceuticals / Nutricosmetics
    Delivery & Dosage Technologies
    Dietary Supplements
    Flavors & Colors
    Functional Foods & Beverages
    Healthcare Trends
    Medical Nutrition
    Mergers & Acquisitions
    Natural/Organic
    Nutrition Bars
    Packaging
    Pet Nutraceuticals
    Quality & Safety
    Regulations
    Research
    Testing
    World Markets

    OptiMSM Shown to Improve Hair & Nail Appearance and Condition

    DCC Acquires Contract Manufacturer Ion Laboratories

    AquaCelle Delivery Technology Shown to Improve Omega-3 Absorption

    Mintel Identifies Global Food and Drink Trends Over Next 10 Years

    Cannabinoid Testing & Quality: Michael Poleselli on the VivAssure Standard
    Bone & Joint Health
    Cancer Risk
    Cardiovascular Health
    Cognitive Function
    Diabetes & Blood Sugar Management
    Digestive Health
    Energy
    Eye Health
    Healthy Aging
    Immune Function
    Infant & Children's Health
    Inflammation
    Men's Health
    Mood Health & Sleep
    Oral Health
    Sexual & Reproductive Health
    Skin Health
    Sports Nutrition
    Weight Management/Weight Loss
    Women's Health

    Pharmactive Affron Saffron May Help Relieve Depression Symptoms

    Maternal 5-MTHF Levels Predict Fetal Folate Status

    Obesity and Gum Disease May Have Common Connection: Inflammation

    Probiotic Strain Shown to Reduce Symptoms of Infant Colic

    Clinical Trial Confirms Joint Health Benefits of NEM Brand Eggshell Membrane in 7 Days
    Industry Events
    Live From Show Events
    Webinars
    All Companies
    Categories
    Trade Associations
    Company Capabilities
    International Buyers Guide Companies
    ExcelVite Sdn. Bhd.

    MitoCarn (Alfasigma)

    Sabinsa Corporation

    PLT Health Solutions

    Aiya America (Matcha by Aiya)
    Companies
    Product Releases
    News Releases
    Literature / Brochures
    White Papers
    Jobs
    VIdeos
    Services
    Add New Company
    International Buyers Guide Companies
    Shanghai Freemen

    Bioenergy Life Science, Inc. (BLS)

    Aiya America (Matcha by Aiya)

    MitoCarn (Alfasigma)

    BatchMaster Software, Inc.
    • Magazine
      • Current / Back Issue
      • Features
      • Editorial
      • Columns
      • Digital Edition
      • eNewsletter Archive
      • Editorial Guidelines
      • Subscribe Now
      • Advertise Now
    • Breaking News
    • Buyers' Guide
      • All Companies
      • Categories
      • Trade Associations
      • Company Capabilities
    • Nutraceuticals
      • Antioxidants
      • Dairy-Based Ingredients
      • Enzymes
      • Fatty Acids
      • Fiber & Carbohydrates
      • Green Foods
      • Herbs & Botanicals
      • Marine Nutraceuticals
      • Minerals
      • Omega 3s
      • Probiotics & Prebiotics
      • Proteins, Peptides, Amino Acids
      • Sweeteners
      • Vitamins
    • Markets
      • Consumer Trends
      • Contract Manufacturing
      • Cosmeceuticals / Nutricosmetics
      • Delivery & Dosage Technologies
      • Dietary Supplements
      • Flavors & Colors
      • Functional Foods & Beverages
      • Healthcare Trends
      • Medical Nutrition
      • Mergers & Acquisitions
      • Natural/Organic
      • Nutrition Bars
      • Packaging
      • Pet Nutraceuticals
      • Quality & Safety
      • Regulations
      • Research
      • Testing
      • World Markets
    • Health
      • Bone & Joint Health
      • Cancer Risk
      • Cardiovascular Health
      • Cognitive Function
      • Diabetes & Blood Sugar Management
      • Digestive Health
      • Energy
      • Eye Health
      • Healthy Aging
      • Immune Function
      • Infant & Children's Health
      • Inflammation
      • Men's Health
      • Mood Health & Sleep
      • Oral Health
      • Sexual & Reproductive Health
      • Skin Health
      • Sports Nutrition
      • Weight Management/Weight Loss
      • Women's Health
    • Online Exclusives
    • Webinars
    • Slideshows
    • Blogs & Guest Articles
    • Health E-Insights
    • Videos
    • Podcasts
    • eBook
    • Infographics
    • Whitepapers
    • Research
      • TrendSense
      • Monograph Center
      • White Papers
      • Research News
    • Jobs
    • Events
      • Industry Events
      • Live From Show Events
      • Webinars
    • Supplier Showcases
      • Companies
      • Product Releases
      • News Releases
      • Literature / Brochures
      • White Papers
      • Jobs
      • VIdeos
      • Services
    • About Us
      • About Us
      • Contact Us
      • Advertise With Us
      • Privacy Policy
      • Terms of Use
    Columns

    Business Insights: The Emerging Market for Medical Foods

    Gregory Stephens, RD, President of Windrose Partners,09.01.12
    Over the past few months there has been quite a bit of activity in the medical foods market. Indeed, industry reports are reflecting consistent and sustainable growth in this multibillion-dollar health and wellness segment. Major pharmaceutical companies are competing head-to-head for market share and acquiring emerging products with growth potential, such as Nestlé Health Science’s recent investment in Axona (more in-depth analysis on this acquisition can be found on page 58 in this issue’s brain health article).
     
    During my 20-year immersion in marketing and business development at Abbott Nutrition (formerly Ross Laboratories), we developed a medical foods franchise with more than $2 billion in sales. The market continues to grow and opportunities are plentiful for those who innovate in this attractive but often misunderstood market. 
     
    Understanding Medical Foods
     
    Medical foods are those that are specially formulated and intended for the dietary management of a disorder, disease or condition that has distinctive nutritional needs that cannot be met by normal diet alone. These criteria were defined in FDA’s 1988 Orphan Drug Act Amendments and are subject to the general food and safety labeling requirements of the Federal Food, Drug, and Cosmetic Act.
     
    A clear distinction can be made between the regulatory classifications of medical foods and dietary supplements. Medical foods must be shown, by medical evaluation, to meet the distinctive nutritional needs of a specific population of patients with a specific disease being targeted. Dietary supplements, on the other hand, are intended for normal, healthy adults and may not require proof of efficacy on the finished product.
     
    Furthermore, medical foods are distinct from the broad category of “foods for special dietary use” and from traditional foods, even those that may qualify for a health claim. 
     
    Prior to 1972, medical foods that mitigated serious adverse effects of underlying diseases were regulated by FDA as “drugs” under the Federal Food, Drug, and Cosmetic Act. Subsequently, in the Orphan Drug Act (1988 Amendment), a medical food was defined as “a food which is formulated to be consumed or administered enterally (orally) under the supervision of a physician, and which is intended for specific dietary management of a disease or condition for which distinctive nutritional requirements, based on recognized scientific principles, are established by medical evaluation.” The other requirements include deomonstrated safety and efficacy.
     
    In an interesting article in Nutrition in Clinical Practice, Sheila Campbell, PhD, RD, provided an insightful glimpse into the history of medical foods, specifically enteral nutrition. When President Garfield was shot in 1881 by assassin James Guiteau, Garfield survived for 79 days. He was given rectal feedings of whiskey and partially hydrolyzed beef and beef broth every four hours for most of that time (Nutr Clin Pract. 2006 Aug;21(4):411-5).
     
    Certainly, the sophistication and administration of medical foods have advanced since those days. Prior to 1972, they were primarily formulated to manage patients with inherited metabolic diseases. They were mainly orphan products for limited populations. Since medical foods were considered drugs, they were regulated accordingly to ensure their use under medical supervision. However, in 1972 FDA reclassified these products from drugs to foods for special dietary use to enhance their development and availability. In the intervening years, a wide variety of products categorized as medical foods was developed.
     
    In relation to the Nutrition Labeling and Education Act of 1990, Congress exempted medical foods from the nutrition labeling, health claim and nutrient disclosure requirements applicable to most other foods, further distinguishing this category from conventional food products.
     
    Market Activity
     
    Certainly, from a sales and market share standpoint, the major pharma players dominate the market. Global sales have been projected at just under $9 billion (Kalorama, 2010; Global Industry Analysts, 2011) with my estimation of the U.S. market easily exceeding $2 billion. This is not what I call a niche market.
     
    The majority of medical food sales are generated by major pharma or CPG companies, including: Abbott Nutrition, Abbott Laboratories (e.g., Glucerna, Nepro, Ensure), Nestlé Health Science, Nestlé SA (e.g., Boost Glucose Control, Novasource Renal) and Nutricia, Groupe Danone (e.g., Fortifit, Souvenaid).
     
    In the U.S. and worldwide, we have seen more than 100 new medical food product launches annually since 2009 (Innova Market Insights, 2011). However, although the major players are the ones launching a significant number of these new products, they are not truly innovative. Most of these launches represent line extensions and brand expansion into new geographies (i.e., countries). This is where these companies are battling for growth and market share. So, what is the source of innovation driving this growth? Taking a close look at the launch of truly, innovative products, we see small to moderate sized biotech and nutritional companies investing in research and driving promotion of new products (e.g., Limbrel, Axona, Glycemx-360, Deplyn, Sentra). 
     
    Of course, after a launch demonstrates promise, the major players are more than willing to invest or acquire the platform. This is precisely what prompted Nestlé Health Science to acquire a stake in Accera, a company that specializes in medical foods for neurodegenerative disorders such as Alzheimer’s. Accera’s main brand is Axona, which is a medical food intended for the dietary management of mild to moderate Alzheimer’s. According to Nestle’s press release, Axona is already being used by 30,000 people. Being generous on compliance, sales are in the single-digit millions, far from a pharmaceutical blockbuster. Keep in mind, however, that products like Abbott Nutrition’s Glucerna had similar sales for oral applications not long ago, and today brand sales likely exceed $200 million. The major players certainly have the sales forces and distribution arms to drive sales and thus do not mind investing in high-potential emerging products.
     
    Common Misconceptions
     
    It is beyond the scope of this column to cover where “white space” in the market exists, or to provide regulatory advice. Rather, I would like to point out a few observations or misconceptions about medical foods I have heard over the years.
     
    Clear and Compelling Label Claims: A benefit of medical food labeling is the ability to reference the disease on the label. Medical food claims refer to the “nutritional or dietary management of a specific disease or its metabolic processes” and must be stated on the label (e.g., Glucerna—“for people with diabetes”).
     
    Premarket Approval by FDA: A similarity between medical foods and dietary supplements is that neither require pre-approval from FDA for marketing, unlike pharmaceutical products.
     
    Distinctive Nutritional Requirements: One often overlooked element is the “distinctive nutritional requirements” standard established by FDA.  Medical foods must be shown, by medical evaluation, to meet the distinctive nutritional needs of a specific diseased patient population being targeted prior to marketing. This is not just the demonstration of efficacy, but rather it must provide: “nutritional support specifically modified for the management of the unique nutrient needs that the dietary management of which cannot be achieved by the modification of the normal diet alone.”
     
    This is not a simple requirement, and FDA has a track record of challenging companies on compliance of their new products, which may require they be pulled from the market.
    Of course, the “distinctive nutritional requirements” of medical foods toward a specific disease must be supported by sound clinical substantiation and by product performance. 
     
    Medical Food Prescriptions: Medical foods do not require a prescription for retail purchase and they are not required to be behind the (pharmacist) counter. It is my understanding that Congress originally used “under physician supervision” in the legislation, which excluded other doctors, dietitians and others with the proper education to administer medical foods. To remedy this, FDA revised it to more appropriately state: “use under medical supervision.”
     
    Opportunities in Medical Foods
    Although medical foods represent a specific FDA regulatory category, healthcare professional awareness of them is relatively low. Additionally, there is  confusion among professionals as to the difference between medical foods and dietary supplements. Reimbursement by Medicare and other third-party payers and patient access (i.e., distribution) are also important opportunities to be addressed.
     
    This can be overcome through education  of medical practitioners that clarifies the unique features of medical foods, including safety and efficacy.                              
     
    Note: Opportunities in the medical food market will be integrated into the program at the upcoming “Healthcare Practitioner Marketing Forum,” April 3-5, 2013 in Long Beach, CA—a conference jointly orchestrated by Holistic Primary Care and Windrose Partners. For more information on this educational event, contact me at GregStephens@WindrosePartners.com. 



    Greg Stephens, RD, is president of Windrose Partners, a company serving clients in the the dietary supplement, functional food and natural product industries. Formerly vice president of strategic consulting with The Natural Marketing Institute (NMI) and Vice President of Sales and Marketing for Nurture, Inc (OatVantage), he has 25 years of specialized expertise in the nutritional and pharmaceutical industries. His prior experience includes a progressive series of senior management positions with Abbott Nutrition (Ross Products Division of Abbott Laboratories), including development of global nutrition strategies for disease-specific growth platforms and business development for Abbott's medical foods portfolio. He can be reached at 215-860-5186; E-mail:gregstephens@windrosepartners.com
     
    Related Searches
    • Brain Health
    • Medical Foods
    • Performance
    • Research
    Related Knowledge Center
    • Medical Nutrition
    • Dietary Supplements
    • Functional Foods & Beverages

    Related Columns

    • Dietary Supplements | Healthcare Trends | Medical Nutrition | Quality & Safety | Regulations | Testing
      Developing Scientific Support for Product Claims

      Developing Scientific Support for Product Claims

      Generally accepted scientific principles should be used to determine the quality of studies used as evidence to substantiate a claim.
      By Greg Stephens, Windrose Partners & Sanford W. Bigelow, PhD, DABT, Vanguard Global Associates LLC 11.05.19

    • Dietary Supplements | Herbs & Botanicals | Natural/Organic | Quality & Safety | Regulations | Testing
      The Wild West Sells More than Just CBD

      The Wild West Sells More than Just CBD

      Self-determined GRAS is not a cure-all for NDINs, so be responsible and conduct the necessary safety and toxicology work.
      By Todd Harrison, Venable 11.05.19

    • Regulations | World Markets
      Regulatory Harmonization in Europe: Setting Daily Reference Values

      Regulatory Harmonization in Europe: Setting Daily Reference Values

      Maximum intake amounts of many micronutrients are still not regulated throughout the EU.
      By Joerg Gruenwald, analyze & realize ag 11.05.19


    • Dietary Supplements | Healthcare Trends | Herbs & Botanicals | Quality & Safety | Research | Testing
      Botanical Science: Post-Exercise Benefits & Neuroprotective Potential

      Botanical Science: Post-Exercise Benefits & Neuroprotective Potential

      AHPA compiles recent research on botanicals and plant compounds published in peer-reviewed journals.
      By Holly Johnson, PhD, American Herbal Products Association (AHPA) 11.05.19

    • Dietary Supplements | Healthcare Trends | Herbs & Botanicals | Medical Nutrition | Quality & Safety | Regulations
      CBD in the Clinic: How Practitioners View Life After the Farm Bill

      CBD in the Clinic: How Practitioners View Life After the Farm Bill

      Holistic, functional medicine practitioners see therapeutic value of CBD and have confidence in its efficacy for a range of common health concerns.
      By Erik Goldman, Holistic Primary Care 10.07.19

    • Dietary Supplements | Healthcare Trends | Herbs & Botanicals | Quality & Safety | Regulations
      CBD Insurance: ‘The Perfume of the Premium’ Strengthens

      CBD Insurance: ‘The Perfume of the Premium’ Strengthens

      The insurance marketplace for hemp growers and CBD manufacturers will continue to expand.
      By Sheldon Baker, Baker Dillon Group LLC 10.07.19


    • Antioxidants | Dietary Supplements | Digestive Health | Herbs & Botanicals | Minerals | Research | Vitamins
      Cinnamon: A Journey from Traditional Flavor to Modern Health Applications

      Cinnamon: A Journey from Traditional Flavor to Modern Health Applications

      A remedy for many ailments in Ayurvedic medicine, science continues to uncover new uses for this common flavoring agent.
      By Dilip Ghosh, PhD, FACN, nutriConnect 10.07.19

    • Dietary Supplements | Healthcare Trends | Quality & Safety | Regulations
      Clinical Nutrition: A New Market Opportunity

      Clinical Nutrition: A New Market Opportunity

      Clearer language and scientific documentation for product benefits could open new doors for nutraceuticals in healthcare settings.
      By Greg Stephens, Windrose Partners, & Sheila Campbell, PhD, RD 09.09.19

    • Dietary Supplements | Herbs & Botanicals | Quality & Safety | Regulations
      CBD Regulatory Status Update: The Chaos Continues

      CBD Regulatory Status Update: The Chaos Continues

      FDA already has the authority to create a legal pathway for cannabidiol. It just needs the will to implement it.
      By Todd Harrison, Venable 09.09.19


    • Dietary Supplements | Healthcare Trends | Herbs & Botanicals | Regulations | World Markets
      Regulatory Harmonization in Europe: CBD Case Study

      Regulatory Harmonization in Europe: CBD Case Study

      Despite long-standing efforts, many EU regulatory standards are still out of alignment.
      By Joerg Gruenwald, analyze & realize ag 09.09.19

    • Herbs & Botanicals | Quality & Safety | Regulations | Testing
      Mile High Labs: Stephen Mueller & The Mile High Monster

      Mile High Labs: Stephen Mueller & The Mile High Monster

      As chief technology officer and founder, he is the technical visionary of Mile High Labs and is designing/building and operating the future of hemp extraction.
      By Sheldon Baker, Baker Dillon Group LLC 07.03.19

    • Dietary Supplements | Regulations | World Markets
      Australia: Leading Regulation of Complementary Medicines

      Australia: Leading Regulation of Complementary Medicines

      The TGA recently implemented a Compliance Rating Scheme for listed medicines.
      By Dilip Ghosh, PhD, FACN, nutriConnect 07.03.19

    • Dietary Supplements | Regulations
      DSHEA Discussion: Assessing Standards for Scientific Evidence

      DSHEA Discussion: Assessing Standards for Scientific Evidence

      Adjusting the health claims system could encourage more clinical trials and benefit consumers.
      By Todd Harrison, Venable 06.03.19

    • Dietary Supplements | Regulations | World Markets
      Non-Specific Health Claims: Beyond the Letter of the Law

      Non-Specific Health Claims: Beyond the Letter of the Law

      These statements are acceptable as long as they are either accepted generic descriptors or accompanied by a specific health claim.
      By Joerg Gruenwald, analyze & realize ag 06.03.19

    • Dietary Supplements | Healthcare Trends | Medical Nutrition | Regulations
      Engaging Doctors in the Dialogue About ‘DSHEA 2.0’

      Engaging Doctors in the Dialogue About ‘DSHEA 2.0’

      The need for clear and truthful clinical communication should be on the table for discussion as DSHEA goes under review.
      By Erik Goldman, Holistic Primary Care 05.02.19

    Breaking News
    • Deerland Obtains Certification from Australia’s Therapeutic Goods Administration
    • OptiMSM Shown to Improve Hair & Nail Appearance and Condition
    • DCC Acquires Contract Manufacturer Ion Laboratories
    • AquaCelle Delivery Technology Shown to Improve Omega-3 Absorption
    • Mintel Identifies Global Food and Drink Trends Over Next 10 Years
    View Breaking News >
    CURRENT ISSUE

    December 2019

    • 2020 International Buyers' Guide
    • 2020 State of the Industry: High Expectations
    • Fueling Cognitive Health through Nutrition & Supplementation
    • View More >
    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    Deerland Obtains Certification from Australia’s Therapeutic Goods Administration
    OptiMSM Shown to Improve Hair & Nail Appearance and Condition
    DCC Acquires Contract Manufacturer Ion Laboratories
    Coatings World

    Latest Breaking News From Coatings World

    Arkema: Bostik Acquires Danish Company LIP
    Axalta Adds New Epoxy Primer to Tufcote Liquid Industrial Coatings Portfolio
    Chromaflo Technologies Promotes Sergio Duenas to Country Manager of Mexico
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    FDA OKs World's First Single-Use Duodenoscope
    Dr. Stephen Hahn Confirmed as New FDA Leader
    FDA OKs First Test to Help Screen for Newborn Duchenne Muscular Dystrophy
    Contract Pharma

    Latest Breaking News From Contract Pharma

    Sanofi Awarded $226M by US Gov't for Pandemic Influenza Preparedness
    Amgen Selects Location For R&D Facility
    Arctoris Opens Oxford R&D Facility
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    Time Features 5 Best Beauty Inventions
    CES 2020 Preview - Innovation Award Honorees in Health & Wellness
    Prada & L’Oréal Sign Long-Term Licensing Deal
    Happi

    Latest Breaking News From Happi

    Cosmetic Assessments Revealed at CIR Panel
    T-Boz Launches CBD Line
    DRF and Flowerkist Develop CBD Range
    Ink World

    Latest Breaking News From Ink World

    Ripon Printers Adds Ricoh Pro C9210
    LogoJet Opens Bogota, Colombia Office
    Canon Solutions America Powers University of Notre Dame Athletics' Printing Capabilities
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    GSE products provide quality assurance for Pharmalabel
    Luminer promotes Heather Bookman to prepress manager
    Materials Exchange launches to solve excess inventory issue
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    DuPont to Acquire Osmosis Specialist
    Nice-Pak to Expand in Indiana
    Hospeco Launches Compact Fem Hy Dispenser
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    FDA OKs First Test to Help Screen for Newborn Duchenne Muscular Dystrophy
    Europe, North America Comprise More Than 80 Percent of Global Bone Marrow Transplantation Demand
    TriMed Closes Out FDA Warning Letter
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    3D Printing Materials Market to Grow at 23.9% CAGR Through 2025: GVR
    Kyocera, TactoTek Collaborate on Injection Molded Structural Electronics Solutions
    Toray Opens R&D Innovation Center for the Future

    Copyright © 2019 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.